MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/coc.0000000000001142

Медицинская библиотека · American journal of clinical oncology · 2024

Does the Primary Tumor Site Drive Biology for Patients With Synovial Sarcoma?

Patel Riddhi R, Delclos George L, DeSantis Stacia M, Cannell Michael B, Lupo Philip J, Bishop Andrew J, Lazar Alexander J, Lin Patrick P, Benjamin Robert S, Patel Shreyaskumar R, Ludwig Joseph, Ravi Vinod, Livingston John Andrew, Somaiah Neeta, Zarzour Maria Alejandra, Conley Anthony P, Araujo Dejka M

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

We evaluated survival outcomes by primary tumor site in synovial sarcoma (SS) patients with localized and metastatic disease at diagnosis.

METHODS

We conducted a retrospective review of 504 SS patients diagnosed from 1974 to 2020. Kaplan-Meier method, log-rank test, and Cox-proportional hazards regression were used.

RESULTS

Among 504 patients, 401 (79.6%) presented with localized disease, and 103 (20.4%) with metastases. For patients with localized disease, (1) 5-year OS by tumor site was as follows: 80% (95% CI, 67%-89%) for head/neck, 30% (95% CI, 18%-42%) for intrathoracic, 51% (95% CI, 35%-65%) for abdomen/pelvis, 71% (95% CI, 62%-79%) for proximal-extremity, and 83% (71%, 91%) for distal-extremity. (2) On multivariable analysis, tumor site (compared with proximal-extremity: intrathoracic tumors [HR: 1.95; 95% CI, 1.22-3.16]; hand/foot [HR: 0.52; 95% CI, 0.28-0.97]), tumor size (compared with <5 cm, 5-10 cm [HR: 1.80; 95% CI, 1.14-2.85]; ≥10 cm [HR: 4.37; 95% CI, 2.69-7.11]), and use of neo/adjuvant radiation (HR: 0.54; 95% CI, 0.37-0.79) remained significantly associated with OS. For patients with metastatic disease, (1) 5-year OS was 12% (95% CI, 6%-21%) and (2) the only factor that remained significantly associated with OS on multivariable analysis was surgical resection for the primary tumor (HR: 0.14; 95% CI, 0.08-0.26).

CONCLUSIONS

The primary tumor location plays a significant role in predicting outcomes for patients with localized SS. Even though patients present with metastatic disease, surgical resection of the primary tumor improves their survival. These findings are critical for patient counseling and designing a personalized treatment plan that reflects the corresponding outcomes.

Для цитирования: Patel Riddhi R, Delclos George L, DeSantis Stacia M, Cannell Michael B, Lupo Philip J, Bishop Andrew J, Lazar Alexander J, Lin Patrick P, Benjamin Robert S, Patel Shreyaskumar R, Ludwig Joseph, Ravi Vinod, Livingston John Andrew, Somaiah Neeta, Zarzour Maria Alejandra, Conley Anthony P, Araujo Dejka M. Does the Primary Tumor Site Drive Biology for Patients With Synovial Sarcoma?. American journal of clinical oncology. 2024. DOI: 10.1097/coc.0000000000001142.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.